Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Postoperative intra-abdominal septic complications [IASCs] are the most feared risks of surgery for Crohn's disease[CD]. The risk factors for IASCs still remain controversial. The aim of this study was to assess the risk factors for IASCs in CD patients undergoing abdominal surgery. METHODS: MEDLINE, Cochrane Library, and EMBASE were searched to identify observational studies reporting the risk factors for IASCs in CD patients. A meta-analysis was conducted to investigate the impact of various risk factors on IASCs in CD. The GRADE [Grading of Recommendations Assessment, Development and Evaluation] approach was used for quality assessment of evidence on outcome levels. RESULTS: This review included 15 studies evaluating 3807 patients undergoing 4189 operations. The meta-analyses found that low albumin levels (odds ratio [OR]: 1.93; 95% confidence interval [CI]: 1.362.75), preoperative steroids use [OR: 1.99; 95% CI: 1.54-2.57], a preoperative abscess [OR: 1.94; 95% CI: 1.263.0], previous surgery history [OR: 1.50; 95% CI: 1.151.97] may be risk factors for IASCs. There were no associations between anastomosis methods [OR: 0.94; 95% CI: 0.58-1.53], biologics therapy [OR: 1.29; 95% CI: 0.792.11], and immunomodulator use [OR: 1.07; 95% CI: 0.661.73] with the risk of IASCs. Due to observational design, the quality of evidence was regarded low or moderate for these risk factors by the GRADE approach. CONCLUSIONS: This meta-analysis provides some evidence that steroids use, previous surgical history, a preoperative abscess, and low albumin levels may be associated with higher rates of IASCs in CD. Knowledge about those risk factors may influence treatment and procedure-related decisions, and possibly reduce the ss rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
(2014) · Medical Entomology and Zoology · Cited by 17,633
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Colombel, J. F., Loftus, E. V., Tremaine, W. J., Pemberton, J. H., Wolff, B. G., Young-Fadok, T., Harmsen, W. S., Schleck, C. D., & Sandborn, W. J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04148.x · Cited by 381
Risk factors for intra-abdominal sepsis after surgery in Crohn's disease
Yamamoto, T., Allan, R. N., & Keighley, M. R. B. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02236563 · Cited by 363 · cited 6×
“…1.97)100.00 El-Hussuna et al 2012 Huang et al 2013 Kanazawa et al 2012 Myrelid et al 2009 Serradori et al 2013 Shental et al 2012 Wang et al 2013 Yamamoto et al 2000 Overall (I - squared = 56.5%, p = 0.024) Note: Weights are from random effects analysis 1.57 (0.86, 2.87) 16.84 0.81 (0.24, 2.77)…”
BackgroundMethodInfluentialRisk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease
Bernell, O., Lapidus, A., & Hellers, G. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01589.x · Cited by 335 · cited 2×
“There are two important limitations involved in this risk factor, which lead to statistical heterogeneity for the outcome measures: [1] concomitant use of immunomodulators; and [2] the cut-off time of immunomodulator therapy before surgery varied considerably [a cut-off time of 2 or 3 months was used among the include…”
MethodAlves, A., Panis, Y., Bouhnik, Y., Pocard, M., Vicaut, E., & Valleur, P. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0782-0 · Cited by 314 · cited 3×
“…9.57 2.01 (1.20, 3.35) 47.54 1.93 (1.36, 2.75) 100.00 OR (95% Cl) % Weight Study ID OR (95% Cl) % Weight Study ID OR (95% Cl) % Weight Study ID Alves et al 2007 El-Hussuna et al 2012 Huang et al 2013 Kanazawa et al 2012 Myrelid et al 2009 Resegotti et al 2005 Serradori et al 2013 Shental et…”
InfluentialSubramanian, V., Saxena, S., Kang, J.-Y., & Pollok, R. C. G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01942.x · Cited by 255
Appau, K. A., Fazio, V. W., Shen, B., Church, J. M., Lashner, B., Remzi, F., Brzezinski, A., Strong, S. A., Hammel, J., & Kiran, R. P. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0646-0 · Cited by 249 · cited 1×
“…29.35 1.17 (0.26, 5.24) 8.72 2.83 (1.16, 6.92) 19.18 0.63 (0.13, 3.07) 7.90 0.79 (0.28, 2.24) 15.57 1.16 (0.48, 2.83) 19.28 1.07 (0.66, 1.73) 100.00 Appau et al 2008 El-Hussuna et al 2012 Myrelid et al 2014 Nasir et al 2010 Serradori et al 2013 Shental et al 2012 Overall (I-squared = 18.7%, p =…”
InfluentialLow preoperative serum albumin in colon cancer: a risk factor for poor outcome
Lai, C.-C., You, J.-F., Yeh, C.-Y., Chen, J.-S., Tang, R., Wang, J.-Y., & Chin, C.-C. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-1113-4 · Cited by 233
Marchal, L., D'Haens, G., Van Assche, G., Vermeire, S., Noman, M., Ferrante, M., Hiele, M., Bueno De Mesquita, M., D'Hoore, A., Penninckx, F., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01904.x · Cited by 222
Kopylov, U., Ben-Horin, S., Zmora, O., Eliakim, R., & Katz, L. H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22954 · Cited by 167
Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer
Richardson, D. L., Mariani, A., & Cliby, W. A. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.003 · Cited by 117
Tay, G., Binion, D. G., Eastwood, D. C., & Otterson, M. F. (2003) · Surgery · doi:10.1016/s0039-6060(03)00298-8 · Cited by 111 · cited 2×
“…al 2007 El-Hussuna et al 2012 Huang et al 2013 Kanazawa et al 2012 Myrelid et al 2009 Resegotti et al 2005 Serradori et al 2013 Shental et al 2012 Tay et al 2003 Tzivanakis et al 2012 Wang et al 2013 Yamamoto et al 2000 Overall (I-squared = 49.1%, P = 0.028) NOTE: Weights are from random effects…”
BackgroundInfluentialEvaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test
Nakarai, A., Kato, J., Hiraoka, S., Kuriyama, M., Akita, M., Hirakawa, T., Okada, H., & Yamamoto, K. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.315 · Cited by 106
Cengiz, Ö., Kocer, B., Sürmeli, S., Santicky, M.-J., & Soran, A. (2006) · PubMed · Cited by 106
Iesalnieks, I., Kilger, A., Glaß, H., Müller‐Wille, R., Klebl, F. H., Ott, C., Strauch, U., Piso, P., Schlitt, H. J., & Agha, A. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0534-9 · Cited by 105
Kanazawa, A., Yamana, T., Okamoto, K., & Sahara, R. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e3182617716 · Cited by 103 · cited 6×
“…(0.45, 6.49) 11.79 0.97 (0.34, 2.78) 17.53 0.69 (0.08, 5.79) 5.05 1.29 (0.79, 2.11) 100.00 Alves et al 2007 El-Hussuna et al 2012 Huang et al 2013 Kanazawa et al 2012 Myrelid et al 2009 Nasir et al 2010 Resegotti et al 2005 Serradori et al 2013 Shental et al 2012 Tzivanakis et al 2012 Wang et al…”
BackgroundInfluentialMyrelid, P., Olaison, G., Sjödahl, R. I., Nyström, P.-O., Almer, S. H., & Andersson, P. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181a7ba96 · Cited by 101 · cited 5×
“…13.41 1.63 (0.61, 4.36) 11.78 0.80 (0.25, 2.56) 9.85 0.77 (0.35, 1.68) 14.53 0.94 (0.58, 1.53) 100.00 El-Hussuna et al 2012 Kanazawa et al 2012 Myrelid et al 2009 Nasir et al 2010 Serradori et al 2013 Shental et al 2012 Overall (I-squared = 30.2%, p = 0.209) 0.70 (0.38, 1.30) 29.35 1.17…”
BackgroundInfluentialImpact of Preoperative Immunosuppressive Agents on Postoperative Outcomes in Crohn’s Disease
Ali, U. A., Martin, S., Rao, A., & Kiran, R. P. (2014) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000099 · Cited by 98
Impairment of macrophage activation and granuloma formation by protein deprivation in mice
Reynolds, J. V., Redmond, H. P., Ueno, N., Steigman, C. K., Ziegler, M. M., Daly, J. M., & Johnston, R. B. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90088-7 · Cited by 97
Canedo, J., Lee, S.-H., Pinto, R. A., MURAD-REGADAS, S. M., Rosen, L., & Wexner, S. D. (2010) · Colorectal Disease · doi:10.1111/j.1463-1318.2010.02469.x · Cited by 96
Li, G., Ren, J., Wang, G., Hu, D., Gu, G., Liu, S., Ren, H., Wu, X., & Li, J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.16 · Cited by 94
Ward, M. W. N., Danzi, M., Lewin, M. R., Rennie, M. J., & Clark, C. G. (1982) · British journal of surgery · doi:10.1002/bjs.1800690604 · Cited by 92
Nørgård, B. M., Nielsen, J., Qvist, N., Gradel, K. O., de Muckadell, O. B. S., & Kjeldsen, J. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12159 · Cited by 85
The effect of immune therapy on surgical site infection following Crohn's Disease resection
Serradori, T., Germain, A., Scherrer, M. L., Ayav, C., Perez, M., Romain, B., Palot, J. P., Rohr, S., Peyrin‐Biroulet, L., & Bresler, L. (2013) · British journal of surgery · doi:10.1002/bjs.9152 · Cited by 82 · cited 6×
“…8.20 2.93 (1.75, 4.90) 15.01 1.94 (1.26, 3.00) 100.00 Alves et al 2007 El-Hussuna et al 2012 Huang et al 2013 Kanazawa et al 2012 Myrelid et 2009 Serradori et al 2013 Shental et al 2012 Wang et al 2013 Yamamoto et al 2000 Overall (I-squared = 0.0%, p = 0.986 ) NOTE: Weights are from random…”
BackgroundInfluentialOperative Management of Small Bowel Crohn's Disease
Gardiner, K. R., & Dasari, B. V. M. (2007) · Surgical Clinics of North America · doi:10.1016/j.suc.2007.03.011 · Cited by 80 · cited 2×
“There are two important limitations involved in this risk factor, which lead to statistical heterogeneity for the outcome measures: [1] concomitant use of immunomodulators; and [2] the cut-off time of immunomodulator therapy before surgery varied considerably [a cut-off time of 2 or 3 months was used among the include…”
MethodWobbes, T., Bemelmans, B. L. H., Jh, K., Beerthuizen, G. I. J. M., & Theeuwes, A. G. M. (1990) · PubMed · Cited by 74
Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients
Indar, A. A., Young‐Fadok, T. M., Heppell, J. P., & Efron, J. E. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-9957-x · Cited by 68
Papaconstantinou, I. G., Zeglinas, C., Gazouli, M., Nastos, C., Yiallourou, A., Papalois, A. E., & Tzathas, C. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-014-2487-3 · Cited by 41
Preoperative Optimization of Crohn Disease
Sharma, A. K., & Chinn, B. T. (2013) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0033-1348044 · Cited by 28
Cited by
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Adamina, M., Bonovas, S., Raine, T., Spinelli, A., Warusavitarne, J., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz187 · Cited by 1,106
A comprehensive review and update on Crohn's disease
Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.07.001 · Cited by 550
Management of Crohn Disease: A Review
Cushing, K., & Higgins, P. D. R. (2021) · JAMA · doi:10.1001/jama.2020.18936 · Cited by 355
Inflammation and malnutrition in inflammatory bowel disease
Massironi, S., Viganò, C., Palermo, A., Pirola, L., Mulinacci, G., Allocca, M., Peyrin-Biroulet, L., & Danese, S. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00011-0 · Cited by 298
Metadata
- Authors
- Huang, W., Tang, Y., Nong, L., & Sun, Y.
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-08
- Volume
- 9
- Issue
- 3
- Pages
- 293-301
- ISSN
- 1873-9946 (ISSN-L)
- 1876-4479
- OpenAlex
- W2167104140
- Cited by
- 175
- References
- 33
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.